MML Investors Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25M | Buy |
49,776
+9,396
| +23% | +$4.51M | 0.05% | 346 |
|
|
2026
Q1 | $19.8M | Buy |
40,380
+5,269
| +15% | +$2.86M | 0.06% | 334 |
|
|
2025
Q4 | $20.3M | Buy |
35,111
+3,749
| +12% | +$2.12M | 0.05% | 357 |
|
|
2025
Q3 | $15.2M | Buy |
31,362
+173
| +0.6% | +$80.5K | 0.04% | 415 |
|
|
2025
Q2 | $12.6M | Sell |
31,189
-13,810
| -31% | -$5.77M | 0.04% | 447 |
|
|
2025
Q1 | $22.4M | Buy |
44,999
+45
| +0.1% | +$24.4K | 0.07% | 263 |
|
|
2024
Q4 | $23.4M | Sell |
44,954
-6,359
| -12% | -$3.5M | 0.08% | 246 |
|
|
2024
Q3 | $31.7M | Buy |
51,313
+3,386
| +7% | +$2M | 0.12% | 187 |
|
|
2024
Q2 | $26.5M | Sell |
47,927
-2,189
| -4% | -$1.25M | 0.11% | 200 |
|
|
2024
Q1 | $29.1M | Buy |
50,116
+4,296
| +9% | +$2.41M | 0.12% | 188 |
|
|
2023
Q4 | $24.3M | Buy |
45,820
+1,280
| +3% | +$620K | 0.11% | 197 |
|
|
2023
Q3 | $22.5M | Sell |
44,540
-1,818
| -4% | -$969K | 0.12% | 178 |
|
|
2023
Q2 | $24.2M | Buy |
46,358
+12,027
| +35% | +$6.49M | 0.13% | 174 |
|
|
2023
Q1 | $19.8M | Sell |
34,331
-5,169
| -13% | -$2.91M | 0.14% | 164 |
|
|
2022
Q4 | $21.8M | Buy |
39,500
+1,078
| +3% | +$571K | 0.14% | 158 |
|
|
2022
Q3 | $19.5M | Buy |
38,422
+2,112
| +6% | +$1.18M | 0.15% | 155 |
|
|
2022
Q2 | $19.7M | Buy |
36,310
+3,193
| +10% | +$1.76M | 0.15% | 154 |
|
|
2022
Q1 | $19.6M | Buy |
33,117
+45
| +0.1% | +$25.9K | 0.14% | 163 |
|
|
2021
Q4 | $22.1M | Buy |
33,072
+1,977
| +6% | +$1.23M | 0.16% | 139 |
|
|
2021
Q3 | $17.8M | Buy |
31,095
+1,539
| +5% | +$845K | 0.14% | 163 |
|
|
2021
Q2 | $14.9M | Buy |
29,556
+1,452
| +5% | +$685K | 0.13% | 181 |
|
|
2021
Q1 | $12.8M | Buy |
28,104
+973
| +4% | +$464K | 0.12% | 187 |
|
|
2020
Q4 | $12.6M | Buy |
27,131
+6,571
| +32% | +$3.08M | 0.14% | 170 |
|
|
2020
Q3 | $9.08M | Buy |
20,560
+2,121
| +12% | +$876K | 0.11% | 187 |
|
|
2020
Q2 | $6.68M | Buy |
18,439
+3,844
| +26% | +$1.29M | 0.09% | 224 |
|
|
2020
Q1 | $4.14M | Buy |
14,595
+3,012
| +26% | +$950K | 0.07% | 254 |
|
|
2019
Q4 | $3.76M | Buy |
11,583
+1,475
| +15% | +$447K | 0.05% | 312 |
|
|
2019
Q3 | $2.94M | Sell |
10,108
-1,028
| -9% | -$294K | 0.05% | 337 |
|
|
2019
Q2 | $3.27M | Buy |
11,136
+934
| +9% | +$257K | 0.05% | 346 |
|
|
2019
Q1 | $2.79M | Buy |
10,202
+1,500
| +17% | +$373K | 0.04% | 364 |
|
|
2018
Q4 | $1.95M | Buy |
8,702
+1,230
| +16% | +$289K | 0.04% | 425 |
|
|
2018
Q3 | $1.82M | Buy |
7,472
+2,563
| +52% | +$590K | 0.03% | 475 |
|
|
2018
Q2 | $1.02M | Sell |
4,909
-369
| -7% | -$78.3K | 0.02% | 556 |
|
|
2018
Q1 | $1.09M | Sell |
5,278
-104
| -2% | -$21.8K | 0.02% | 522 |
|
|
2017
Q4 | $1.02M | Buy |
5,382
+948
| +21% | +$182K | 0.02% | 542 |
|
|
2017
Q3 | $839K | Buy |
4,434
+611
| +16% | +$111K | 0.02% | 573 |
|
|
2017
Q2 | $667K | Buy |
3,823
+302
| +9% | +$50.7K | 0.01% | 661 |
|
|
2017
Q1 | $541K | Buy |
+3,521
| New | +$538K | 0.01% | 426 |
|
Other funds holding TMO
MML Investors Services's TMO Position: Q2 2026 in Review
MML Investors Services increased its Thermo Fisher Scientific (TMO) stake by 23% in Q2 2026, buying an estimated $4.51M and bringing the position to 49,776 shares worth $25M. The position accounts for 0.05% of the portfolio, ranked #346.
MML Investors Services first reported a position in TMO in Q1 2017 and has held it in 38 quarters since. The position peaked at $31.7M in Q3 2024. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- MML Investors Services held 49,776 shares of Thermo Fisher Scientific worth $25M as of Q2 2026.
- MML Investors Services bought 9,396 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.51M.
- Thermo Fisher Scientific made up 0.05% of MML Investors Services's portfolio in Q2 2026, its #346 holding.
- MML Investors Services first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 38 quarters since.
- MML Investors Services's Thermo Fisher Scientific position peaked at $31.7M in Q3 2024.
- 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.